We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

NWFL:NASDAQNorwood Financial Corp. Analysis

Data as of 2026-09-01 - not real-time

$34.16

Latest Price

4/10Risk

Risk Level: Medium

Executive Summary

At $34.16, Norwood Financial Corp. shows a bullish moving-average alignment, with shorter averages sitting above longer ones. The last 30 days have gained 9.3%. RSI sits at 57.3, which reads as neutral, and MACD momentum is bearish. Watch $32.92 as support and $34.90 as the nearer resistance level.
Valuation screens as undervalued: a P/E of 11.7 sits below the sector average of 16.9. Consensus targets land 6.9% above where the shares trade now. Revenue is growing at 34.7% on a 28.9% profit margin. The 3.75% dividend yield looks covered by current payout levels.
Risk comes out at 4 of a possible 10, a moderate reading. With 30-day volatility of 24.5%, a beta of 0.22 and a maximum drawdown of 12.9%, position sizing matters here. The wider market backdrop reads extreme greed at 95 on the fear-greed composite.
All three time horizons resolve to buy, carrying 7/10 conviction.

Top Market Events

Norwood Financial's 44% revenue beat was undercut by a sharp spike in problem loans after a $22 million commercial real...If you buy and hold a stock for many years, you'd hope to be making a profit.Norwood Financial Corp. NWFL came out with quarterly earnings of $0.86 per share, missing the Zacks Consensus Estimate...

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 6/10

Key Factors

  • Short-term moving averages stacked above long-term ones
  • Trading above the 200-day average of 30.38
  • MACD momentum is negative

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Short-term moving averages stacked above long-term ones
  • P/E of 11.7 versus sector average of 16.9
  • Trading above the 200-day average of 30.38

Long Term

> 3 years
Positive
Model confidence: 7/10

Key Factors

  • P/E of 11.7 versus sector average of 16.9
  • Analyst targets imply +6.9% versus the current price
  • Profit margin of 28.9% is healthy

Key Metrics & Analysis

Financial Health

Revenue Growth34.70%
Profit Margin28.93%
P/E Ratio11.7
ROE11.20%
ROA1.09%
P/B Ratio1.3
Op. Cash Flow$33.0M
Industry P/E16.9

Technical Analysis

TrendBullish
RSI57.3
Support$32.92
Resistance$34.90
MA 20$34.04
MA 50$32.82
MA 200$30.38
MACDBearish
VolumeDecreasing
Fear & Greed Index94.79

Valuation

Fair Value$73.11
Target Price$36.50
Upside/Downside6.85%
GradeUndervalued
TypeValue
Dividend Yield3.75%

Risk Assessment

Beta0.22
Volatility24.47%
Sector RiskMedium
Reg. RiskHigh
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.